60 DEGREES PHARMACEUTICALS, INC.
SXTP · XNASCIK 1946563fmd_15FFQQK6KQ5BYSVCWHAM0WEXCTManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2022 to Jun 30, 2026, 18 periods
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Total revenues | 0 | 0 | 1 | 1 |
| Cost of revenue | 0 | 0 | 0 | 1 |
| Net interest income | (4) | 1 | – | – |
| Gross profit | (0) | (0) | 0 | 0 |
| Research and development | 1 | 1 | 5 | 2 |
| Total operating expenses | 2 | 5 | 10 | 8 |
| Operating income | (2) | (5) | (10) | (8) |
| Interest expense | 4 | 2 | 0 | 0 |
| Other non-operating income (expense) | (0) | (0) | 2 | 0 |
| Income before taxes | (6) | (4) | (8) | (7) |
| Income tax expense | 0 | 0 | 0 | 0 |
| Net income from continuing operations | 0 | (0) | (8) | (7) |
| Net income | (6) | (4) | (8) | (7) |
| Net income to common shareholders | (6) | (4) | (8) | (8) |